Complete List of PARP inhibitor Medicines
                
                
                
                    
                    
                        Brand: ZEJULA | 
                        Strength: 100 mg | 
                        Form: Capsules
                    
                    
                    
                        Class: | PARP inhibitor  
Use: | Treatment of adult patients with recurrent ovarian cancer, including those with BRCA mutations, who have received 1 or more prior lines of chemotherapy  
Adult dose: |...
                    
                    
                 
                
                
                    
                    
                        Brand: ZEJULA | 
                        Strength: 100 mg | 
                        Form: Capsules
                    
                    
                    
                        Class: | PARP inhibitor  
Use: | Treatment of adult patients with recurrent ovarian, fallopian tube, or primary peritoneal cancer who have responded to platinum-based chemotherapy  
Adult dose: | 300 ...
                    
                    
                 
                
                
                    
                    
                        Brand: ZEJULA | 
                        Strength: 100 mg | 
                        Form: Tablets
                    
                    
                    
                        Class: | PARP inhibitor  
Use: | Treatment of adult patients with recurrent ovarian cancer, including those with BRCA mutation, following response to platinum-based chemotherapy  
Adult dose: | 300 mg...
                    
                    
                 
                
                
                    
                    
                        Brand: ZEJULA | 
                        Strength: 100 mg | 
                        Form: Tablets
                    
                    
                    
                        Class: | PARP inhibitor  
Use: | Treatment of adult patients with recurrent ovarian cancer, including those with BRCA mutations, following response to platinum-based chemotherapy.  
Adult dose: | 300 ...
                    
                    
                 
                
                
                    
                    
                        Brand: LYNPARZA | 
                        Strength: 100 mg | 
                        Form: Tablets
                    
                    
                    
                        Class: | PARP inhibitor  
Use: | Treatment of adult patients with deleterious or suspected deleterious germline BRCA-mutated advanced ovarian cancer, breast cancer, pancreatic cancer, and prostate can...
                    
                    
                 
                
                
                    
                    
                        Brand: LYNPARZA | 
                        Strength: 150 mg | 
                        Form: Tablets
                    
                    
                    
                        Class: | PARP inhibitor  
Use: | Treatment of adult patients with deleterious or suspected deleterious germline BRCA-mutated advanced ovarian cancer, breast cancer, pancreatic cancer, and prostate can...
                    
                    
                 
                
                
                    
                    
                        Brand: LYNPARZA | 
                        Strength: 50 mg | 
                        Form: Capsules
                    
                    
                    
                        Class: | PARP inhibitor  
Use: | Treatment of adult patients with deleterious or suspected deleterious germline BRCA-mutated advanced ovarian cancer, breast cancer, pancreatic cancer, and prostate can...
                    
                    
                 
                
                
                    
                    
                        Brand: TALZENNA | 
                        Strength: 0.25 mg | 
                        Form: Capsules
                    
                    
                    
                        Class:| PARP inhibitor  
Use:| Treatment of adult patients with deleterious or suspected deleterious germline BRCA-mutated HER2-negative locally advanced or metastatic breast cancer  
Adult dose:| 1 m...
                    
                    
                 
                
                
                    
                    
                        Brand: TALZENNA | 
                        Strength: 1 mg | 
                        Form: Capsules
                    
                    
                    
                        Class:| PARP inhibitor  
Use:| Treatment of adult patients with deleterious or suspected deleterious germline BRCA-mutated, HER2-negative locally advanced or metastatic breast cancer  
Adult dose:| 1 ...
                    
                    
                 
                
                
                    
                    
                        Brand: TALZENNA | 
                        Strength: 0.1 | 
                        Form: Hard Hypromellose - Capsule
                    
                    
                    
                        Class:| PARP (Poly ADP-Ribose Polymerase) inhibitor  
Use:| Treatment of adult patients with deleterious or suspected deleterious germline BRCA-mutated HER2-negative locally advanced or metastatic bre...
                    
                    
                 
                
                
                    
                    
                        Brand: TALZENNA | 
                        Strength: 0.35 mg/1 Capsule | 
                        Form: Hard Hypromellose - Capsule
                    
                    
                    
                        Class:| PARP inhibitor  
Use:| Treatment of adult patients with deleterious or suspected deleterious germline BRCA-mutated HER2-negative locally advanced or metastatic breast cancer.  
Adult dose:| 0....
                    
                    
                 
                
                
                    
                    
                        Brand: TALZENNA | 
                        Strength: 0.5 mg/1 Capsule | 
                        Form: Capsules
                    
                    
                    
                        Class:| PARP inhibitor  
Use:| Treatment of adult patients with deleterious or suspected deleterious germline BRCA-mutated HER2-negative locally advanced or metastatic breast cancer.  
Adult dose:| 1 ...